Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients (Q86120631)
Jump to navigation
Jump to search
scientific article published on 11 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients |
scientific article published on 11 February 2013 |
Statements
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients (English)
Sajo Kaduthanam
Stephan Gade
Michael Meister
Jan C Brase
Marc Johannes
Hendrik Dienemann
Arne Warth
Philipp A Schnabel
Felix J F Herth
Thomas Muley
Ruprecht Kuner
11 February 2013